EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Combined treatment with valacyclovir and heparin reduced the incidence of equine herpesvirus myeloencephalopathy and improved survival in naturally occurring equine herpesvirus-1 outbreaks

Megan Marchitello iD, Krista Estell iD, Elsa K Ludwig iD, Abby M Sage, Nathaniel A White iD

Journal of the American Veterinary Medical Association · 10.07.2026 · 1-6

DOI: 10.2460/javma.26.02.0118 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Veterinary Medical Association, erschienen am 10.07.2026. Verfasst von Megan Marchitello und 4 weiteren Autor:innen. Beteiligte Einrichtung: 1Marion duPont Scott Equine Medical Center, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Le…. Hauptthemen laut MEDLINE: Horse Diseases, Valacyclovir, Herpesvirus 1, Equid, Herpesviridae Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Describe the effects and outcomes of valacyclovir and heparin administration in equine herpesvirus-1 (EHV-1)–exposed horses.

Methods

A multicenter retrospective study identified 111 horses naturally exposed to EHV-1 from August 2017 to March 2018. Equine herpesvirus-1 infection was confirmed via blood or nasal secretion PCR. Horses that developed neurologic signs were diagnosed with equine herpesvirus myeloencephalopathy (EHM). Clinical signs, treatment, and survival were reported. A subset of horses was treated with valacyclovir and heparin. Prophylactic medication administration was performed prior to development of EHV-1 clinical signs (temperature > 38.6 °C, limb edema, nasal discharge, or neurologic deficits). Medication administration to clinical cases was defined as metaphylactic. Survival and EHM incidence were assessed between horses that received valacyclovir and heparin and horses that did not.

Results

22 horses were diagnosed with EHV-1, with 9 developing EHM. Fourteen EHV-1–positive horses received metaphylactic valacyclovir and heparin, with 5 developing EHM. Five EHV-1–positive horses received prophylactic valacyclovir and metaphylactic heparin, with 1 developing EHM. Four EHV-1 horses were not treated with valacyclovir or heparin; all developed grade 5/5 ataxia and were euthanized. All horses treated with valacyclovir and heparin survived.

Conclusions

EHV-1 treatment with valacyclovir and heparin reduced the incidence of EHM and improved survival compared to horses that did not receive these medications. Clinical Relevance In confirmed EHV-1 outbreaks, the administration of valacyclovir prior to the development of EHV-1 clinical signs and the administration of heparin after the development of clinical signs may improve patient survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Horse DiseasesValacyclovirHerpesvirus 1, EquidHerpesviridae InfectionsAntiviral AgentsHeparinAnimalsHorsesRetrospective StudiesFemaleDisease OutbreaksMaleIncidenceDrug Therapy, Combination

Stichwörter der Autor:innen

encephalopathyequine herpesvirus myeloencephalopathyequine herpesvirus-1heparinvalacyclovir

Substanzen

ValacyclovirAntiviral AgentsHeparin

Autor:innen und Institutionen

  • 1Marion duPont Scott Equine Medical Center, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Leesburg, VA.
  • 2Zoetis-Global Animal Health Co, Parsippany, NJ.

ORCID-Profile: Megan Marchitello, Krista Estell, Elsa K Ludwig, Nathaniel A White

Zitieren

APA

Marchitello, M., Estell, K., Ludwig, E. K., Sage, A. M., & White, N. A. (2026). Combined treatment with valacyclovir and heparin reduced the incidence of equine herpesvirus myeloencephalopathy and improved survival in naturally occurring equine herpesvirus-1 outbreaks. Journal of the American Veterinary Medical Association, 1-6. https://doi.org/10.2460/javma.26.02.0118

Vancouver

Marchitello M, Estell K, Ludwig EK, Sage AM, White NA. Combined treatment with valacyclovir and heparin reduced the incidence of equine herpesvirus myeloencephalopathy and improved survival in naturally occurring equine herpesvirus-1 outbreaks. Journal of the American Veterinary Medical Association. 2026:1-6. doi:10.2460/javma.26.02.0118

BibTeX
@article{Marchitello2026,
  author = {Marchitello, Megan and Estell, Krista and Ludwig, Elsa K and Sage, Abby M and White, Nathaniel A},
  title = {Combined treatment with valacyclovir and heparin reduced the incidence of equine herpesvirus myeloencephalopathy and improved survival in naturally occurring equine herpesvirus-1 outbreaks},
  journal = {Journal of the American Veterinary Medical Association},
  year = {2026},
  pages = {1--6},
  doi = {10.2460/javma.26.02.0118}
}
Kostenlos starten →